A Glimpse Into the Future of Rheumatology

David Pisetsky MD, new President-elect of the US Bone and Joint Initiative, is likely to be influential  in defining the path of rheumatology in coming years. Listen here as he speaks about the role of rheumatologists in a patient-centered, multidisciplinary medical future.


About half of rheumatoid arthritis patients don't understand enough information to make intelligent treatment choices. Here's how to help.

A new meta-analysis shows RA treatments have varied effects on patients’ response to flu and pneumonia vaccines.

psoriatic arthritis

At its 2014 annual meeting, GRAPPA continues development of criteria to help non-rheumatologists spot psoriatic arthritis.

With some historical analysis, a British rheumatologist unearths a persuasive explanation for the emergence of rheumatoid arthritis when and where it did, in fact, arise.

Chlamydia trachomatis

About one in 20 patients with genital chlamydia, the most prevalent sexually transmitted disease in the US, progress to reactive arthritis. This is simple to treat, but devilish to detect and diagnose.

The latest of numerous tofacitinib trials in rheumatoid arthritis, this one (head-to-head against methotrexate monotherapy) has results in line with previous research. Like others, it is unable to resolve a major question about risk.

A new tool could help ophthalmologists who see uveitis collaborate in the early diagnosis of spondyloarthritis.


Subscribe to Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.